Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer

Carmela Ricciardelli, Keiko Mayne, Pam Sykes, Wendy Raymond, Kieran McCaul, Villis Marshall, Wayne Tilley, John Skinner, David Horsfall

    Research output: Contribution to journalArticle

    71 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)983-992
    Number of pages10
    JournalClinical Cancer Research
    Volume3
    Publication statusPublished - 1997

    Cite this

    Ricciardelli, C., Mayne, K., Sykes, P., Raymond, W., McCaul, K., Marshall, V., Tilley, W., Skinner, J., & Horsfall, D. (1997). Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clinical Cancer Research, 3, 983-992.